Abstract
Summary
LPI (LP Information)' newest research report, the “Ophthalmic Viscoelastic Agent Industry Forecast” looks at past sales and reviews total world Ophthalmic Viscoelastic Agent sales in 2022, providing a comprehensive analysis by region and market sector of projected Ophthalmic Viscoelastic Agent sales for 2023 through 2029. With Ophthalmic Viscoelastic Agent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ophthalmic Viscoelastic Agent industry.
This Insight Report provides a comprehensive analysis of the global Ophthalmic Viscoelastic Agent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ophthalmic Viscoelastic Agent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Ophthalmic Viscoelastic Agent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ophthalmic Viscoelastic Agent and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ophthalmic Viscoelastic Agent.
The global Ophthalmic Viscoelastic Agent market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Ophthalmic Viscoelastic Agent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Ophthalmic Viscoelastic Agent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Ophthalmic Viscoelastic Agent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Ophthalmic Viscoelastic Agent players cover Alcon Inc, Shanghai Haohai Biological Technology, Bausch & Lomb Inc, Abbott Medical Optics,Inc., LG Life Sciences, Johnson & Johnson Vision, Zeiss, Ellex Medical Laser Limited and Huvitz Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmic Viscoelastic Agent market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Cohesive Viscoelastic
Low Viscosity Dispersion Viscoelastic
Segmentation by application
Cataract Surgery
Myopia Surgery
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Alcon Inc
Shanghai Haohai Biological Technology
Bausch & Lomb Inc
Abbott Medical Optics,Inc.
LG Life Sciences
Johnson & Johnson Vision
Zeiss
Ellex Medical Laser Limited
Huvitz Co., Ltd.
Iridex Corp.
Lumenis Ltd.
Nidek Co. Ltd
Topcon Corporation
Visionix Ltd
Eyebright Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Ophthalmic Viscoelastic Agent market?
What factors are driving Ophthalmic Viscoelastic Agent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ophthalmic Viscoelastic Agent market opportunities vary by end market size?
How does Ophthalmic Viscoelastic Agent break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
This Insight Report provides a comprehensive analysis of the global Ophthalmic Viscoelastic Agent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ophthalmic Viscoelastic Agent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Ophthalmic Viscoelastic Agent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ophthalmic Viscoelastic Agent and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ophthalmic Viscoelastic Agent.
The global Ophthalmic Viscoelastic Agent market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Ophthalmic Viscoelastic Agent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Ophthalmic Viscoelastic Agent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Ophthalmic Viscoelastic Agent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Ophthalmic Viscoelastic Agent players cover Alcon Inc, Shanghai Haohai Biological Technology, Bausch & Lomb Inc, Abbott Medical Optics,Inc., LG Life Sciences, Johnson & Johnson Vision, Zeiss, Ellex Medical Laser Limited and Huvitz Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmic Viscoelastic Agent market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Cohesive Viscoelastic
Low Viscosity Dispersion Viscoelastic
Segmentation by application
Cataract Surgery
Myopia Surgery
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Alcon Inc
Shanghai Haohai Biological Technology
Bausch & Lomb Inc
Abbott Medical Optics,Inc.
LG Life Sciences
Johnson & Johnson Vision
Zeiss
Ellex Medical Laser Limited
Huvitz Co., Ltd.
Iridex Corp.
Lumenis Ltd.
Nidek Co. Ltd
Topcon Corporation
Visionix Ltd
Eyebright Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Ophthalmic Viscoelastic Agent market?
What factors are driving Ophthalmic Viscoelastic Agent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ophthalmic Viscoelastic Agent market opportunities vary by end market size?
How does Ophthalmic Viscoelastic Agent break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ophthalmic Viscoelastic Agent Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Ophthalmic Viscoelastic Agent by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Ophthalmic Viscoelastic Agent by Country/Region, 2018, 2022 & 2029
2.2 Ophthalmic Viscoelastic Agent Segment by Type
2.2.1 Cohesive Viscoelastic
2.2.2 Low Viscosity Dispersion Viscoelastic
2.3 Ophthalmic Viscoelastic Agent Sales by Type
2.3.1 Global Ophthalmic Viscoelastic Agent Sales Market Share by Type (2018-2023)
2.3.2 Global Ophthalmic Viscoelastic Agent Revenue and Market Share by Type (2018-2023)
2.3.3 Global Ophthalmic Viscoelastic Agent Sale Price by Type (2018-2023)
2.4 Ophthalmic Viscoelastic Agent Segment by Application
2.4.1 Cataract Surgery
2.4.2 Myopia Surgery
2.4.3 Other
2.5 Ophthalmic Viscoelastic Agent Sales by Application
2.5.1 Global Ophthalmic Viscoelastic Agent Sale Market Share by Application (2018-2023)
2.5.2 Global Ophthalmic Viscoelastic Agent Revenue and Market Share by Application (2018-2023)
2.5.3 Global Ophthalmic Viscoelastic Agent Sale Price by Application (2018-2023)
3 Global Ophthalmic Viscoelastic Agent by Company
3.1 Global Ophthalmic Viscoelastic Agent Breakdown Data by Company
3.1.1 Global Ophthalmic Viscoelastic Agent Annual Sales by Company (2018-2023)
3.1.2 Global Ophthalmic Viscoelastic Agent Sales Market Share by Company (2018-2023)
3.2 Global Ophthalmic Viscoelastic Agent Annual Revenue by Company (2018-2023)
3.2.1 Global Ophthalmic Viscoelastic Agent Revenue by Company (2018-2023)
3.2.2 Global Ophthalmic Viscoelastic Agent Revenue Market Share by Company (2018-2023)
3.3 Global Ophthalmic Viscoelastic Agent Sale Price by Company
3.4 Key Manufacturers Ophthalmic Viscoelastic Agent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ophthalmic Viscoelastic Agent Product Location Distribution
3.4.2 Players Ophthalmic Viscoelastic Agent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Ophthalmic Viscoelastic Agent by Geographic Region
4.1 World Historic Ophthalmic Viscoelastic Agent Market Size by Geographic Region (2018-2023)
4.1.1 Global Ophthalmic Viscoelastic Agent Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Ophthalmic Viscoelastic Agent Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Ophthalmic Viscoelastic Agent Market Size by Country/Region (2018-2023)
4.2.1 Global Ophthalmic Viscoelastic Agent Annual Sales by Country/Region (2018-2023)
4.2.2 Global Ophthalmic Viscoelastic Agent Annual Revenue by Country/Region (2018-2023)
4.3 Americas Ophthalmic Viscoelastic Agent Sales Growth
4.4 APAC Ophthalmic Viscoelastic Agent Sales Growth
4.5 Europe Ophthalmic Viscoelastic Agent Sales Growth
4.6 Middle East & Africa Ophthalmic Viscoelastic Agent Sales Growth
5 Americas
5.1 Americas Ophthalmic Viscoelastic Agent Sales by Country
5.1.1 Americas Ophthalmic Viscoelastic Agent Sales by Country (2018-2023)
5.1.2 Americas Ophthalmic Viscoelastic Agent Revenue by Country (2018-2023)
5.2 Americas Ophthalmic Viscoelastic Agent Sales by Type
5.3 Americas Ophthalmic Viscoelastic Agent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmic Viscoelastic Agent Sales by Region
6.1.1 APAC Ophthalmic Viscoelastic Agent Sales by Region (2018-2023)
6.1.2 APAC Ophthalmic Viscoelastic Agent Revenue by Region (2018-2023)
6.2 APAC Ophthalmic Viscoelastic Agent Sales by Type
6.3 APAC Ophthalmic Viscoelastic Agent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ophthalmic Viscoelastic Agent by Country
7.1.1 Europe Ophthalmic Viscoelastic Agent Sales by Country (2018-2023)
7.1.2 Europe Ophthalmic Viscoelastic Agent Revenue by Country (2018-2023)
7.2 Europe Ophthalmic Viscoelastic Agent Sales by Type
7.3 Europe Ophthalmic Viscoelastic Agent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ophthalmic Viscoelastic Agent by Country
8.1.1 Middle East & Africa Ophthalmic Viscoelastic Agent Sales by Country (2018-2023)
8.1.2 Middle East & Africa Ophthalmic Viscoelastic Agent Revenue by Country (2018-2023)
8.2 Middle East & Africa Ophthalmic Viscoelastic Agent Sales by Type
8.3 Middle East & Africa Ophthalmic Viscoelastic Agent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ophthalmic Viscoelastic Agent
10.3 Manufacturing Process Analysis of Ophthalmic Viscoelastic Agent
10.4 Industry Chain Structure of Ophthalmic Viscoelastic Agent
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ophthalmic Viscoelastic Agent Distributors
11.3 Ophthalmic Viscoelastic Agent Customer
12 World Forecast Review for Ophthalmic Viscoelastic Agent by Geographic Region
12.1 Global Ophthalmic Viscoelastic Agent Market Size Forecast by Region
12.1.1 Global Ophthalmic Viscoelastic Agent Forecast by Region (2024-2029)
12.1.2 Global Ophthalmic Viscoelastic Agent Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ophthalmic Viscoelastic Agent Forecast by Type
12.7 Global Ophthalmic Viscoelastic Agent Forecast by Application
13 Key Players Analysis
13.1 Alcon Inc
13.1.1 Alcon Inc Company Information
13.1.2 Alcon Inc Ophthalmic Viscoelastic Agent Product Portfolios and Specifications
13.1.3 Alcon Inc Ophthalmic Viscoelastic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Alcon Inc Main Business Overview
13.1.5 Alcon Inc Latest Developments
13.2 Shanghai Haohai Biological Technology
13.2.1 Shanghai Haohai Biological Technology Company Information
13.2.2 Shanghai Haohai Biological Technology Ophthalmic Viscoelastic Agent Product Portfolios and Specifications
13.2.3 Shanghai Haohai Biological Technology Ophthalmic Viscoelastic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Shanghai Haohai Biological Technology Main Business Overview
13.2.5 Shanghai Haohai Biological Technology Latest Developments
13.3 Bausch & Lomb Inc
13.3.1 Bausch & Lomb Inc Company Information
13.3.2 Bausch & Lomb Inc Ophthalmic Viscoelastic Agent Product Portfolios and Specifications
13.3.3 Bausch & Lomb Inc Ophthalmic Viscoelastic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Bausch & Lomb Inc Main Business Overview
13.3.5 Bausch & Lomb Inc Latest Developments
13.4 Abbott Medical Optics,Inc.
13.4.1 Abbott Medical Optics,Inc. Company Information
13.4.2 Abbott Medical Optics,Inc. Ophthalmic Viscoelastic Agent Product Portfolios and Specifications
13.4.3 Abbott Medical Optics,Inc. Ophthalmic Viscoelastic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Abbott Medical Optics,Inc. Main Business Overview
13.4.5 Abbott Medical Optics,Inc. Latest Developments
13.5 LG Life Sciences
13.5.1 LG Life Sciences Company Information
13.5.2 LG Life Sciences Ophthalmic Viscoelastic Agent Product Portfolios and Specifications
13.5.3 LG Life Sciences Ophthalmic Viscoelastic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 LG Life Sciences Main Business Overview
13.5.5 LG Life Sciences Latest Developments
13.6 Johnson & Johnson Vision
13.6.1 Johnson & Johnson Vision Company Information
13.6.2 Johnson & Johnson Vision Ophthalmic Viscoelastic Agent Product Portfolios and Specifications
13.6.3 Johnson & Johnson Vision Ophthalmic Viscoelastic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Johnson & Johnson Vision Main Business Overview
13.6.5 Johnson & Johnson Vision Latest Developments
13.7 Zeiss
13.7.1 Zeiss Company Information
13.7.2 Zeiss Ophthalmic Viscoelastic Agent Product Portfolios and Specifications
13.7.3 Zeiss Ophthalmic Viscoelastic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Zeiss Main Business Overview
13.7.5 Zeiss Latest Developments
13.8 Ellex Medical Laser Limited
13.8.1 Ellex Medical Laser Limited Company Information
13.8.2 Ellex Medical Laser Limited Ophthalmic Viscoelastic Agent Product Portfolios and Specifications
13.8.3 Ellex Medical Laser Limited Ophthalmic Viscoelastic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Ellex Medical Laser Limited Main Business Overview
13.8.5 Ellex Medical Laser Limited Latest Developments
13.9 Huvitz Co., Ltd.
13.9.1 Huvitz Co., Ltd. Company Information
13.9.2 Huvitz Co., Ltd. Ophthalmic Viscoelastic Agent Product Portfolios and Specifications
13.9.3 Huvitz Co., Ltd. Ophthalmic Viscoelastic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Huvitz Co., Ltd. Main Business Overview
13.9.5 Huvitz Co., Ltd. Latest Developments
13.10 Iridex Corp.
13.10.1 Iridex Corp. Company Information
13.10.2 Iridex Corp. Ophthalmic Viscoelastic Agent Product Portfolios and Specifications
13.10.3 Iridex Corp. Ophthalmic Viscoelastic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Iridex Corp. Main Business Overview
13.10.5 Iridex Corp. Latest Developments
13.11 Lumenis Ltd.
13.11.1 Lumenis Ltd. Company Information
13.11.2 Lumenis Ltd. Ophthalmic Viscoelastic Agent Product Portfolios and Specifications
13.11.3 Lumenis Ltd. Ophthalmic Viscoelastic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Lumenis Ltd. Main Business Overview
13.11.5 Lumenis Ltd. Latest Developments
13.12 Nidek Co. Ltd
13.12.1 Nidek Co. Ltd Company Information
13.12.2 Nidek Co. Ltd Ophthalmic Viscoelastic Agent Product Portfolios and Specifications
13.12.3 Nidek Co. Ltd Ophthalmic Viscoelastic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Nidek Co. Ltd Main Business Overview
13.12.5 Nidek Co. Ltd Latest Developments
13.13 Topcon Corporation
13.13.1 Topcon Corporation Company Information
13.13.2 Topcon Corporation Ophthalmic Viscoelastic Agent Product Portfolios and Specifications
13.13.3 Topcon Corporation Ophthalmic Viscoelastic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Topcon Corporation Main Business Overview
13.13.5 Topcon Corporation Latest Developments
13.14 Visionix Ltd
13.14.1 Visionix Ltd Company Information
13.14.2 Visionix Ltd Ophthalmic Viscoelastic Agent Product Portfolios and Specifications
13.14.3 Visionix Ltd Ophthalmic Viscoelastic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Visionix Ltd Main Business Overview
13.14.5 Visionix Ltd Latest Developments
13.15 Eyebright Medical
13.15.1 Eyebright Medical Company Information
13.15.2 Eyebright Medical Ophthalmic Viscoelastic Agent Product Portfolios and Specifications
13.15.3 Eyebright Medical Ophthalmic Viscoelastic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Eyebright Medical Main Business Overview
13.15.5 Eyebright Medical Latest Developments
14 Research Findings and Conclusion